Chronic Heart Failure Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Ventricular Assist Devices (VADs), Implantable Cardioverter Defibrillators (ICD), Pacemakers, Cardiac Resynchronization Therapy, Counter Pulsation Devices); End User (Hospitals, Specialized Cardiovascular Disease Treatment Centers, Ambulatory Surgical Centers), and geography

Report Code: TIPRE00018030 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Heart failure (HF) is a disorder with a high level of mortality and morbidity. With a rising elderly population, its prevalence is increasing. Heart failure is treated with medical therapy using a tiered strategy due to decreased left ventricular ejection fraction. To keep the heart beating at a regular rate, a cardiac device is used. Several types of devices are available. If the patient has reduced ejection fraction (HF-rEF) heart failure and requires a device, the doctor can help to figure out what sort of device is suitable for the patient's needs.

MARKET DYNAMICS

Factors driving the growth of the chronic heart failure treatment market are the growing prevalence of cardiovascular diseases (CVD), coupled with increasing technological advanced products. However, the high cost of devices and stringent regulation and approval is expected to hamper the growth of the market. Moreover, favorable reimbursement policies and rising geriatric population is anticipated to boost the market growth.

MARKET SCOPE

The "Chronic Heart Failure Devices Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of chronic heart failure devices market with detailed market segmentation by product type and end user. The chronic heart failure devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in chronic heart failure devices market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The chronic heart failure devices market is segmented on the basis of product type and end user. Based on product type, the market is segmented as Ventricular Assist Devices (VADs), Implantable Cardioverter Defibrillators (ICD), Pacemakers, cardiac resynchronization therapy, and counter pulsation devices. Implantable Cardioverter Defibrillators (ICD) is sub segmented as Subcutaneous ICD and Transvenous ICD. Pacemakers is sub segmented as external and implantable. Cardiac resynchronization therapy is sub segmented as Cardiac Resynchronization Therapy-Pacemakers (CRT-P) and Cardiac Resynchronization Therapy-Defibrillators (CRT-D). On the basis of raw material, the market is as hospitals, specialized cardiovascular disease treatment centers, and ambulatory surgical centers.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the chronic heart failure devices market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The chronic heart failure devices market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting chronic heart failure devices market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the chronic heart failure devices market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the chronic heart failure devices market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from chronic heart failure devices market are anticipated to have lucrative growth opportunities in the future with the rising demand for chronic heart failure devices in the global market. Below mentioned is the list of few companies engaged in the chronic heart failure devices market.

The report also includes the profiles of key players in chronic heart failure devices market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Boston Scientific Corporation
  •  Medtronic PLC
  •  Abiomed, Inc.
  •  HeartWare International, Inc.
  •  Jarvik Heart, Inc.
  •  LivaNova PLC
  •  ReliantHeart Inc.
  •  Biotronik SE & Co., KG
  •  Jude Medical
  •  Berlin Heart Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Chronic Heart Failure Treatment Devices Market - By Product Type
1.3.2 Chronic Heart Failure Treatment Devices Market - By End User
1.3.3 Chronic Heart Failure Treatment Devices Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CHRONIC HEART FAILURE TREATMENT DEVICES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CHRONIC HEART FAILURE TREATMENT DEVICES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CHRONIC HEART FAILURE TREATMENT DEVICES MARKET - GLOBAL MARKET ANALYSIS
6.1. CHRONIC HEART FAILURE TREATMENT DEVICES - GLOBAL MARKET OVERVIEW
6.2. CHRONIC HEART FAILURE TREATMENT DEVICES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. CHRONIC HEART FAILURE TREATMENT DEVICES MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. VENTRICULAR ASSIST DEVICES (VADS)
7.3.1. Overview
7.3.2. Ventricular Assist Devices (VADs) Market Forecast and Analysis
7.3.3. RVAD Market
7.3.3.1. Overview
7.3.3.2. RVAD Market Forecast and Analysis
7.3.4. LVAD Market
7.3.4.1. Overview
7.3.4.2. LVAD Market Forecast and Analysis
7.3.5. BiVAD Market
7.3.5.1. Overview
7.3.5.2. BiVAD Market Forecast and Analysis
7.4. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD)
7.4.1. Overview
7.4.2. Implantable Cardioverter Defibrillators (ICD) Market Forecast and Analysis
7.4.3. Subcutaneous ICD Market
7.4.3.1. Overview
7.4.3.2. Subcutaneous ICD Market Forecast and Analysis
7.4.4. Transvenous ICD Market
7.4.4.1. Overview
7.4.4.2. Transvenous ICD Market Forecast and Analysis
7.5. PACEMAKERS
7.5.1. Overview
7.5.2. Pacemakers Market Forecast and Analysis
7.5.3. External Market
7.5.3.1. Overview
7.5.3.2. External Market Forecast and Analysis
7.5.4. Implantable Market
7.5.4.1. Overview
7.5.4.2. Implantable Market Forecast and Analysis
7.6. CARDIAC RESYNCHRONIZATION THERAPY
7.6.1. Overview
7.6.2. Cardiac Resynchronization Therapy Market Forecast and Analysis
7.6.3. Cardiac Resynchronization Therapy-Pacemakers (CRT-P) Market
7.6.3.1. Overview
7.6.3.2. Cardiac Resynchronization Therapy-Pacemakers (CRT-P) Market Forecast and Analysis
7.6.4. Cardiac Resynchronization Therapy-Defibrillators (CRT-D) Market
7.6.4.1. Overview
7.6.4.2. Cardiac Resynchronization Therapy-Defibrillators (CRT-D) Market Forecast and Analysis
7.7. COUNTER PULSATION DEVICES
7.7.1. Overview
7.7.2. Counter Pulsation Devices Market Forecast and Analysis
8. CHRONIC HEART FAILURE TREATMENT DEVICES MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. SPECIALIZED CARDIOVASCULAR DISEASE TREATMENT CENTERS
8.4.1. Overview
8.4.2. Specialized Cardiovascular Disease Treatment Centers Market Forecast and Analysis
8.5. AMBULATORY SURGICAL CENTERS
8.5.1. Overview
8.5.2. Ambulatory Surgical Centers Market Forecast and Analysis
9. CHRONIC HEART FAILURE TREATMENT DEVICES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Chronic Heart Failure Treatment Devices Market Overview
9.1.2 North America Chronic Heart Failure Treatment Devices Market Forecasts and Analysis
9.1.3 North America Chronic Heart Failure Treatment Devices Market Forecasts and Analysis - By Product Type
9.1.4 North America Chronic Heart Failure Treatment Devices Market Forecasts and Analysis - By End User
9.1.5 North America Chronic Heart Failure Treatment Devices Market Forecasts and Analysis - By Countries
9.1.5.1 United States Chronic Heart Failure Treatment Devices Market
9.1.5.1.1 United States Chronic Heart Failure Treatment Devices Market by Product Type
9.1.5.1.2 United States Chronic Heart Failure Treatment Devices Market by End User
9.1.5.2 Canada Chronic Heart Failure Treatment Devices Market
9.1.5.2.1 Canada Chronic Heart Failure Treatment Devices Market by Product Type
9.1.5.2.2 Canada Chronic Heart Failure Treatment Devices Market by End User
9.1.5.3 Mexico Chronic Heart Failure Treatment Devices Market
9.1.5.3.1 Mexico Chronic Heart Failure Treatment Devices Market by Product Type
9.1.5.3.2 Mexico Chronic Heart Failure Treatment Devices Market by End User
9.2. EUROPE
9.2.1 Europe Chronic Heart Failure Treatment Devices Market Overview
9.2.2 Europe Chronic Heart Failure Treatment Devices Market Forecasts and Analysis
9.2.3 Europe Chronic Heart Failure Treatment Devices Market Forecasts and Analysis - By Product Type
9.2.4 Europe Chronic Heart Failure Treatment Devices Market Forecasts and Analysis - By End User
9.2.5 Europe Chronic Heart Failure Treatment Devices Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Chronic Heart Failure Treatment Devices Market
9.2.5.1.1 Germany Chronic Heart Failure Treatment Devices Market by Product Type
9.2.5.1.2 Germany Chronic Heart Failure Treatment Devices Market by End User
9.2.5.2 France Chronic Heart Failure Treatment Devices Market
9.2.5.2.1 France Chronic Heart Failure Treatment Devices Market by Product Type
9.2.5.2.2 France Chronic Heart Failure Treatment Devices Market by End User
9.2.5.3 Italy Chronic Heart Failure Treatment Devices Market
9.2.5.3.1 Italy Chronic Heart Failure Treatment Devices Market by Product Type
9.2.5.3.2 Italy Chronic Heart Failure Treatment Devices Market by End User
9.2.5.4 Spain Chronic Heart Failure Treatment Devices Market
9.2.5.4.1 Spain Chronic Heart Failure Treatment Devices Market by Product Type
9.2.5.4.2 Spain Chronic Heart Failure Treatment Devices Market by End User
9.2.5.5 United Kingdom Chronic Heart Failure Treatment Devices Market
9.2.5.5.1 United Kingdom Chronic Heart Failure Treatment Devices Market by Product Type
9.2.5.5.2 United Kingdom Chronic Heart Failure Treatment Devices Market by End User
9.2.5.6 Rest of Europe Chronic Heart Failure Treatment Devices Market
9.2.5.6.1 Rest of Europe Chronic Heart Failure Treatment Devices Market by Product Type
9.2.5.6.2 Rest of Europe Chronic Heart Failure Treatment Devices Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Chronic Heart Failure Treatment Devices Market Overview
9.3.2 Asia-Pacific Chronic Heart Failure Treatment Devices Market Forecasts and Analysis
9.3.3 Asia-Pacific Chronic Heart Failure Treatment Devices Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Chronic Heart Failure Treatment Devices Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Chronic Heart Failure Treatment Devices Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Chronic Heart Failure Treatment Devices Market
9.3.5.1.1 Australia Chronic Heart Failure Treatment Devices Market by Product Type
9.3.5.1.2 Australia Chronic Heart Failure Treatment Devices Market by End User
9.3.5.2 China Chronic Heart Failure Treatment Devices Market
9.3.5.2.1 China Chronic Heart Failure Treatment Devices Market by Product Type
9.3.5.2.2 China Chronic Heart Failure Treatment Devices Market by End User
9.3.5.3 India Chronic Heart Failure Treatment Devices Market
9.3.5.3.1 India Chronic Heart Failure Treatment Devices Market by Product Type
9.3.5.3.2 India Chronic Heart Failure Treatment Devices Market by End User
9.3.5.4 Japan Chronic Heart Failure Treatment Devices Market
9.3.5.4.1 Japan Chronic Heart Failure Treatment Devices Market by Product Type
9.3.5.4.2 Japan Chronic Heart Failure Treatment Devices Market by End User
9.3.5.5 South Korea Chronic Heart Failure Treatment Devices Market
9.3.5.5.1 South Korea Chronic Heart Failure Treatment Devices Market by Product Type
9.3.5.5.2 South Korea Chronic Heart Failure Treatment Devices Market by End User
9.3.5.6 Rest of Asia-Pacific Chronic Heart Failure Treatment Devices Market
9.3.5.6.1 Rest of Asia-Pacific Chronic Heart Failure Treatment Devices Market by Product Type
9.3.5.6.2 Rest of Asia-Pacific Chronic Heart Failure Treatment Devices Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Chronic Heart Failure Treatment Devices Market Overview
9.4.2 Middle East and Africa Chronic Heart Failure Treatment Devices Market Forecasts and Analysis
9.4.3 Middle East and Africa Chronic Heart Failure Treatment Devices Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Chronic Heart Failure Treatment Devices Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Chronic Heart Failure Treatment Devices Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Chronic Heart Failure Treatment Devices Market
9.4.5.1.1 South Africa Chronic Heart Failure Treatment Devices Market by Product Type
9.4.5.1.2 South Africa Chronic Heart Failure Treatment Devices Market by End User
9.4.5.2 Saudi Arabia Chronic Heart Failure Treatment Devices Market
9.4.5.2.1 Saudi Arabia Chronic Heart Failure Treatment Devices Market by Product Type
9.4.5.2.2 Saudi Arabia Chronic Heart Failure Treatment Devices Market by End User
9.4.5.3 U.A.E Chronic Heart Failure Treatment Devices Market
9.4.5.3.1 U.A.E Chronic Heart Failure Treatment Devices Market by Product Type
9.4.5.3.2 U.A.E Chronic Heart Failure Treatment Devices Market by End User
9.4.5.4 Rest of Middle East and Africa Chronic Heart Failure Treatment Devices Market
9.4.5.4.1 Rest of Middle East and Africa Chronic Heart Failure Treatment Devices Market by Product Type
9.4.5.4.2 Rest of Middle East and Africa Chronic Heart Failure Treatment Devices Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Chronic Heart Failure Treatment Devices Market Overview
9.5.2 South and Central America Chronic Heart Failure Treatment Devices Market Forecasts and Analysis
9.5.3 South and Central America Chronic Heart Failure Treatment Devices Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Chronic Heart Failure Treatment Devices Market Forecasts and Analysis - By End User
9.5.5 South and Central America Chronic Heart Failure Treatment Devices Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Chronic Heart Failure Treatment Devices Market
9.5.5.1.1 Brazil Chronic Heart Failure Treatment Devices Market by Product Type
9.5.5.1.2 Brazil Chronic Heart Failure Treatment Devices Market by End User
9.5.5.2 Argentina Chronic Heart Failure Treatment Devices Market
9.5.5.2.1 Argentina Chronic Heart Failure Treatment Devices Market by Product Type
9.5.5.2.2 Argentina Chronic Heart Failure Treatment Devices Market by End User
9.5.5.3 Rest of South and Central America Chronic Heart Failure Treatment Devices Market
9.5.5.3.1 Rest of South and Central America Chronic Heart Failure Treatment Devices Market by Product Type
9.5.5.3.2 Rest of South and Central America Chronic Heart Failure Treatment Devices Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CHRONIC HEART FAILURE TREATMENT DEVICES MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CHRONIC HEART FAILURE TREATMENT DEVICES MARKET, KEY COMPANY PROFILES
12.1. BOSTON SCIENTIFIC CORPORATION
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. MEDTRONIC PLC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ABIOMED, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. HEARTWARE INTERNATIONAL, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. JARVIK HEART, INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. LIVANOVA PLC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. RELIANTHEART INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BIOTRONIK SE AND CO., KG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. JUDE MEDICAL
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BERLIN HEART INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Boston Scientific Corporation
2. Medtronic PLC
3. Abiomed, Inc.
4. HeartWare International, Inc.
5. Jarvik Heart, Inc.
6. LivaNova PLC
7. ReliantHeart Inc.
8. Biotronik SE & Co., KG
9. Jude Medical
10. Berlin Heart Inc.
TIPRE00018030
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking